A European Community Advisory Board (ECAB) online meeting between members from EATG and Merck Sharp and Dohme will be held on the 27th of June to discuss HPV vaccine efficacy and safety data, delivery and R&D.
The European Community Advisory Board (ECAB) is a platform that brings together civil society, scientific researchers, the pharmaceutical industry and other stakeholders to address key science and access issues related to HIV and its main co-infections. It is a network of individual community experts and people living with HIV who represent the diverse needs, interests, and concerns of the European HIV community. ECAB members meet regularly with key stakeholders to ensure the HIV community is represented and listened to in the research and development process.
Practical Information
- European Community Advisory Board meeting with Merck Sharp and Dohme (July 2023): Date: 4 July 2023
Where: online
Registration link: Only for EATG members
Related Events
-
European Community Advisory Board meeting on HIV with Gilead Sciences, ViiV Healthcare & Janssen (September 2023)
-
European Community Advisory Board meeting on HIV with Gilead Sciences, ViiV Healthcare & Merck Sharp and Dohme (March-April 2023)
-
European Community Advisory Board meeting with Merck Sharp and Dohme & ViiV Healthcare (October 2022)
-
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.